- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Fatty Liver in United Kingdom
Total 4334 results
-
Madrigal Pharmaceuticals, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Spain, Australia, United Kingdom, Canada, Israel, Belgium, Italy, France, Puerto Rico, Switzerland, Germany, Austria, Poland, Mexico, Hungary
-
AstraZenecaAstraZeneca K.K.RecruitingNonalcoholic SteatohepatitisUnited States, China, Korea, Republic of, Germany, Japan, Spain, Vietnam, Argentina, Colombia, Peru, Brazil, Malaysia, Taiwan, Thailand, Italy, Turkey, Hong Kong, Singapore, India, Mexico, Chile, Philippines, Portugal
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Taiwan, Netherlands, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Mexico, Puerto Rico
-
Conatus Pharmaceuticals Inc.CompletedLiver Diseases | Fibrosis | Non-alcoholic SteatohepatitisUnited States, Spain, Germany
-
Indiana UniversityRecruitingNASH - Nonalcoholic Steatohepatitis | Cirrhosis, LiverUnited States
-
Mirum Pharmaceuticals, Inc.CompletedNon-Alcoholic SteatohepatitisUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Zydus Therapeutics Inc.RecruitingNonalcoholic SteatohepatitisUnited States
-
St. Louis UniversityHoffmann-La RocheCompletedHepatitis | Fatty LiverUnited States
-
Hepion Pharmaceuticals, Inc.Active, not recruitingNAFLD | Nonalcoholic Steatohepatitis (NASH) | Fibrosis, LiverUnited States, France, Mexico
-
Massachusetts General HospitalNational Institute of Allergy and Infectious Diseases (NIAID)CompletedNonalcoholic Steatohepatitis (NASH) | Human Immunodeficiency Virus (HIV) | Nonalcoholic Fatty Liver Disease (NAFLD)United States
-
Zydus Therapeutics Inc.RecruitingFibrosis | Nonalcoholic SteatohepatitisUnited States, Turkey, Argentina
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
National Institute of Diabetes and Digestive and...Completed
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Albert...Not yet recruitingInsulin Resistance | Prediabetic State | Overweight and Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Viking Therapeutics, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Mexico, Puerto Rico
-
Intercept PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, Finland, France, Spain, United Kingdom, Israel, Austria, Italy, Denmark, Germany, Belgium, Switzerland, Puerto Rico, Poland, Australia, Sweden, Serbia, New Zealand, Canada, Hungary, Portugal
-
Boehringer IngelheimRecruitingObesity | Non-alcoholic Fatty Liver DiseaseUnited States
-
Forma Therapeutics, Inc.ProSciento, Inc.TerminatedNonalcoholic Steatohepatitis (NASH) | Overweight or ObesityUnited States
-
University of California, DavisCompletedMetabolic Syndrome | Nonalcoholic SteatohepatitisUnited States
-
University of Texas Southwestern Medical CenterCompletedObesity | Fatty Liver | Metabolic Syndrome | NAFLDUnited States
-
Duke UniversityCompletedDiabetes Mellitus | NAFLDUnited States
-
Columbia UniversityUniversity of California, BerkeleyRecruitingInsulin Resistance | Prediabetic State | Overweight and Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Gyongyi SzaboNational Institute on Alcohol Abuse and Alcoholism (NIAAA); The Cleveland Clinic and other collaboratorsWithdrawnHepatic SteatosisUnited States
-
Virginia Commonwealth UniversityOridionCompletedFatty Liver | CirrhosisUnited States
-
Regeneron PharmaceuticalsRecruitingNon-alcoholic Steatohepatitis (NASH) | Metabolic Dysfunction Associated Steatohepatitis (MASH)United States, Korea, Republic of, Puerto Rico, Japan
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Galmed Research and Development, Ltd.SuspendedNonalcoholic Steatohepatitis (NASH)United States
-
Lidia SzczepaniakForest LaboratoriesCompleted
-
Bettina MittendorferNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Not yet recruitingHealthy | Obesity | Diabetes Type 2 | Nonalcoholic Fatty LiverUnited States
-
New Discovery LLCNYU Langone Health; Stanford University; Baylor University; Rush University; Wuxi...RecruitingFatty Liver | Liver FibrosisUnited States
-
National Institute of Allergy and Infectious Diseases...The University of Texas Health Science Center, HoustonCompletedHIV Infections | Non-Alcoholic Fatty Liver DiseaseUnited States, Brazil
-
University of UlsterLund University; University of Rochester; Ministry of Health, Republic of SeychellesCompletedPolyunsaturated Fatty Acid (PUFA) StatusUnited Kingdom
-
Stanford UniversityCompletedLiver Cirrhosis | Liver SteatosesUnited States
-
Columbia UniversityCompletedInsulin Resistance | Dyslipidemias | HyperinsulinemiaUnited States
-
Sonic IncytesCompletedLiver Steatosis | Liver FibrosisUnited States, Canada
-
Inventiva PharmaRecruitingNASH - Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Austria, Belgium, France, Germany, Israel, Portugal, Spain, United Kingdom, Canada, Italy, China, Brazil, Netherlands, Hungary, Bulgaria, Chile, Czechia, Mexico, Poland, Puerto Rico, South Africa, Uk...
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Duke...Recruiting
-
Andres Duarte-RojoCompletedLiver Disease | Early Allograft Dysfunction | Liver Steatosis | Liver Transplant | Primary Non-functionUnited States
-
AstraZenecaParexelCompletedNon-alcoholic Steatohepatitis (NASH)United States
-
Gilead SciencesCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Canada
-
Boston PharmaceuticalsActive, not recruitingNonalcoholic Steatohepatitis (NASH)United States
-
AstraZenecaCompletedNon-cirrhotic Non-alcoholic Steatohepatitis With FibrosisUnited States, Austria, Italy, Thailand, Germany, Korea, Republic of, Japan, Malaysia, New Zealand, Spain, Taiwan, Turkey, Australia, Israel, Argentina, Canada, Greece, South Africa, United Kingdom, France
-
GenfitTerminatedNonalcoholic Steatohepatitis (NASH) With FibrosisUnited States, Belgium, Germany, France, Canada, Netherlands, Italy, Switzerland, Finland, Puerto Rico, United Kingdom, Denmark, Spain, Australia, Czechia, Sweden, Romania, Argentina, Portugal, Turkey, Mexico, Colombia, South Africa, ... and more
-
Johns Hopkins UniversityResMed FoundationCompletedObstructive Sleep Apnea | Non Alcoholic Fatty Liver DiseaseUnited States
-
Metacrine, Inc.Active, not recruitingDiabetes | Fatty Liver | Type 2 Diabetes | NAFLD | NASH - Nonalcoholic Steatohepatitis | Diabetes Type 2 | NASH | Fatty Liver, NonalcoholicUnited States
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Fatty LiverUnited States
-
University of Alabama at BirminghamCompletedInsulin Resistance | Non-alcoholic Fatty Liver Disease | Childhood ObesityUnited States